All Relations between Movement Disorders and dopamine

Publication Sentence Publish Date Extraction Date Species
Ahmed Bouhouche, Leila Tamaoui, Nazha Birou. The Pan African medical journal. vol 47. 2024-07-08. PMID:38974698. dopa-responsive dystonia (drd) is a hereditary movement disorder due to a selective nigrostriatal dopamine deficiency. 2024-07-08 2024-07-11 Not clear
Hannah Holden, Shruti Venkatesh, Carla Budrow, Sareen Nezaria, Michael Coyle, Ashley Centner, Natalie Lipari, Grace McManus, Christopher Bisho. The effects of L-DOPA on gait abnormalities in a unilateral 6-OHDA rat model of Parkinson's disease. Physiology & behavior. vol 281. 2024-05-25. PMID:38723388. parkinson's disease (pd) is a neurodegenerative movement disorder characterized by dopamine (da) cell loss in the substantia nigra pars compacta (snc). 2024-05-25 2024-05-27 rat
Ratna Dini Haryuni, Takamasa Nukui, Jin-Lan Piao, Takashi Shirakura, Chieko Matsui, Tomoyuki Sugimoto, Kousuke Baba, Shunya Nakane, Yuji Nakatsuj. Elevated Serum Xanthine Oxidase and Its Correlation with Antioxidant Status in Patients with Parkinson's Disease. Biomolecules. vol 14. issue 4. 2024-04-27. PMID:38672506. parkinson's disease (pd) is a neurodegenerative movement disorder associated with a loss of dopamine neurons in the substantia nigra. 2024-04-27 2024-04-29 Not clear
Jerzy K Kulski, Shingo Suzuki, Takashi Shiina, Abigail L Pfaff, Sulev Kõk. Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson's disease. Frontiers in immunology. vol 15. 2024-04-09. PMID:38590523. parkinson's disease (pd) is a neurodegenerative and polygenic disorder characterised by the progressive loss of neural dopamine and onset of movement disorders. 2024-04-09 2024-04-11 human
Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Hui-Fang Shang, Thien Thien Lim, Jin Whan Cho, Pramod Kumar Pal, Hirohisa Watanab. Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway. Frontiers in neurology. vol 15. 2024-02-29. PMID:38419696. tardive dyskinesia (td) is a movement disorder that can arise as a side effect of treatment with dopamine receptor-blocking agents (drbas), including antipsychotic drugs (apds) used to manage psychotic illnesses. 2024-02-29 2024-03-02 Not clear
Suzita Mohd Noor, Chee Ern David Wong, Pooi-Fong Wong, Anwar Norazi. Generation of glial cell-derived neurotrophic factor (gdnf) morphants in zebrafish larvae by cerebroventricular microinjection of vivo morpholino. Methods in cell biology. vol 181. 2024-02-01. PMID:38302238. deficiency of dopamine due to advanced age and accumulative dopaminergic neuron defects can lead to movement disorders such as parkinson's disease. 2024-02-01 2024-02-04 human
Louisa A Christie, Nicola L Brice, Anna Rowland, Louise Dickson, Rishi Anand, Martin Teall, Kevin J Doyle, Lakshminarayana Narayana, Christine Mitchell, Jenna R M Harvey, Victoria Mulligan, Lee A Dawson, Stephanie J Cragg, Mark Carlton, Roland W Bürl. Discovery of Journal of medicinal chemistry. 2023-08-31. PMID:37651656. this subunit modulates dopamine neurotransmission and may have therapeutic potential in movement disorders. 2023-08-31 2023-09-07 Not clear
Gabriella Tandra, Amy Yoone, Rhea Mathew, Minzhi Wang, Chadwick M Hales, Cassie S Mitchel. Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson's Disease. International journal of molecular sciences. vol 24. issue 15. 2023-08-12. PMID:37569714. parkinson's disease (pd) is a movement disorder caused by a dopamine deficit in the brain. 2023-08-12 2023-08-16 Not clear
Leslie Citrome, Jonathan M Meye. Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management. The Journal of clinical psychiatry. vol 84. issue 4. 2023-08-09. PMID:37555680. for decades, treatment for schizophrenia has focused on antipsychotics (aps) that reduce excess dopamine signaling to the associative striatum, which also blocks dopamine signaling in the dorsal striatum, creating movement disorders. 2023-08-09 2023-08-16 Not clear
Z A Zalyalov. [Tardive dyskinesia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. 2023-07-25. PMID:37490662. tardive dyskinesia (td) is a delayed, often irreversible iatrogenic movement disorder caused by long-term use of that dopamine receptors blocking drugs. 2023-07-25 2023-08-14 Not clear
Robert B Kargb. Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Parkinson's Disease and Amyotrophic Lateral Sclerosis. ACS medicinal chemistry letters. vol 14. issue 7. 2023-07-19. PMID:37465304. parkinson's disease (pd) is a neurodegenerative movement disorder characterized by symptoms like resting tremor, rigidity, bradykinesia, and postural instability, mainly due to dopamine depletion and degeneration of dopaminergic neurons. 2023-07-19 2023-08-14 Not clear
Joanne Ng, Serena Barral, Simon N Waddington, Manju A Kuria. Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches. Cells. vol 12. issue 13. 2023-07-14. PMID:37443770. infantile parkinsonism-dystonia due to dopamine transporter deficiency syndrome (dtds) is an ultrarare childhood movement disorder caused by biallelic loss-of-function mutations in the 2023-07-14 2023-08-14 Not clear
Lenka Hasíková, Jakub Závada, Tereza Serranová, Petr Kozlík, Květa Kalíková, Lenka Kotačková, Jiří Trnka, David Zogala, Karel Šonka, Evžen Růžička, Petr Duše. Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease. NPJ Parkinson's disease. vol 9. issue 1. 2023-04-12. PMID:37045835. pd patients were examined using movement disorder society-unified parkinson's disease rating scale (mds-updrs), montreal cognitive assessment (moca), scales for outcomes in parkinson disease-autonomic (scopa-aut), the university of pennsylvania smell identification test (upsit), one-night video-polysomnography, and dopamine transporter single-photon emission computed tomography (dat-spect). 2023-04-12 2023-08-14 Not clear
Kaitlyn M Roman, Maria A Briscione, Yuping Donsante, Jordan Ingram, Xueliang Fan, Douglas Bernhard, Simone A Campbell, Anthony M Downs, David Gutman, Tejas A Sardar, Sofia Q Bonno, Diane J Sutcliffe, H A Jinnah, Ellen J Hes. Striatal subregion-selective dysregulated dopamine receptor-mediated intracellular signaling in a model of DOPA-responsive dystonia. Neuroscience. 2023-03-05. PMID:36871883. although adaptations in striatal dopamine receptor-mediated intracellular signaling have been studied extensively in models of parkinson's disease, another movement disorders associated with dopamine deficiency, little is known about dopaminergic adaptations in dystonia. 2023-03-05 2023-08-14 mouse
Yu-Hsuan Chen, Yi-Ying Kuo, Yi-Qian You, Ya-Tin Lin, Pei-Chun Che. Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease. Journal of neurochemistry. 2023-02-25. PMID:36840377. parkinson's disease (pd) is a common movement disorder caused by a characteristic loss of dopaminergic neurons in the substantia nigra (sn) and degeneration of dopamine terminals in the dorsal striatum. 2023-02-25 2023-08-14 mouse
Katsunori Kitan. The network configuration in Parkinsonian state compensates network activity change caused by loss of dopamine. Physiological reports. vol 11. issue 4. 2023-02-21. PMID:36802196. parkinson's disease is a movement disorder caused by dopamine depletion in the basal ganglia. 2023-02-21 2023-08-14 Not clear
Tahereh Sohrabi, Behnaz Mirzaei-Behbahani, Ramin Zadali, Mitra Pirhaghi, Ludmilla A Morozova-Roche, Ali Akbar Merata. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease. Journal of molecular biology. 2023-02-03. PMID:36736886. parkinson's disease (pd) is the most common neurological movement disorder characterized by the selective and irreversible loss of dopaminergic neurons in substantia nigra pars compacta resulting in dopamine deficiency in the striatum. 2023-02-03 2023-08-14 Not clear
Yasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsum. Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan. Therapeutic advances in psychopharmacology. vol 12. 2023-01-05. PMID:36601351. tardive dyskinesia (td) is a movement disorder that can develop with the use of dopamine receptor-blocking agents and is most commonly caused by antipsychotics. 2023-01-05 2023-08-14 Not clear
Juan Carlos Magaña, Cláudia M Deus, Maria Giné-Garriga, Joel Montané, Susana P Pereir. Exercise-Boosted Mitochondrial Remodeling in Parkinson's Disease. Biomedicines. vol 10. issue 12. 2022-12-23. PMID:36551984. parkinson's disease (pd) is a movement disorder characterized by the progressive degeneration of dopaminergic neurons resulting in dopamine deficiency in the 2022-12-23 2023-08-14 Not clear
Koki Nagaoka, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kanek. Acetaminophen improves tardive akathisia induced by dopamine D Journal of pharmacological sciences. vol 151. issue 1. 2022-12-15. PMID:36522124. acetaminophen improves tardive akathisia induced by dopamine d tardive akathisia is a movement disorder characterized by internal restlessness with an uncontrollable urge to move, leading to repetitive movements. 2022-12-15 2023-08-14 Not clear